Health
Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India – Medical Xpress
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial…
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across Indiaone of the world’s most ethnically diverse countries. Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in critically ill patients.
…
-
General21 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News23 hours agoSunshine Coast women celebrated at 26th annual business awards
-
Noosa News15 hours agoThe only person detained at Brisbane’s Palestine rally
-
Noosa News24 hours agoNew FLC President has regional lens – Proctor